tiprankstipranks
Trending News
More News >
Clover Corporation Limited (AU:CLV)
ASX:CLV

Clover Corporation Limited (CLV) AI Stock Analysis

Compare
7 Followers

Top Page

AU

Clover Corporation Limited

(Sydney:CLV)

Rating:64Neutral
Price Target:
AU$0.50
▼(-7.41%Downside)
Clover Corporation Limited's overall stock score is primarily influenced by its solid financial position and reasonable valuation, despite declining revenue and profitability. The technical analysis indicates moderate momentum, with caution advised due to nearing overbought conditions. The absence of earnings call insights and corporate events means these areas did not impact the overall score.

Clover Corporation Limited (CLV) vs. iShares MSCI Australia ETF (EWA)

Clover Corporation Limited Business Overview & Revenue Model

Company DescriptionClover Corporation Limited (CLV) is an Australian-based company specializing in the development and production of unique, high-quality ingredients for the food, beverage, and nutraceutical industries. The company is renowned for its innovative encapsulation technology, which enhances the stability and bioavailability of sensitive oils such as omega-3 fatty acids. CLV's products are used globally in a variety of applications, including infant formula, dietary supplements, and functional foods, supporting health and wellness initiatives worldwide.
How the Company Makes MoneyClover Corporation Limited generates revenue primarily through the manufacture and sale of its proprietary encapsulated ingredients. The company's key revenue streams include sales of products like omega-3 DHA powders and other specialty ingredients that are incorporated into a wide range of consumer products. CLV's advanced encapsulation technology allows it to command premium pricing for its offerings, adding value by enhancing the nutritional profile and shelf life of end products. Additionally, the company may enter into strategic partnerships and collaborations with major food and nutraceutical companies to expand its market reach and drive additional sales. Factors such as global health trends and increasing consumer awareness of the benefits of omega-3 fatty acids contribute to the demand for Clover's products, supporting its financial performance.

Clover Corporation Limited Financial Statement Overview

Summary
Clover Corporation Limited faces challenges with declining revenue and profitability, yet maintains a strong balance sheet and solid cash flow generation. The company's low leverage and high equity ratio offer stability, but declining ROE and margins are concerning. The ability to generate cash flow amidst decreasing profitability is a strength, but addressing top-line growth and margins is critical for future performance.
Income Statement
55
Neutral
Clover Corporation Limited has experienced a significant decline in revenue and profitability over the past year. The gross profit margin decreased from 29.72% to 27.10%, and the net profit margin dropped from 7.77% to 2.44%. Revenue fell by 22.14% year-over-year, indicating challenges in maintaining sales. The EBIT margin also decreased from 12.47% to 5.03%. These metrics suggest pressure on both the top and bottom lines.
Balance Sheet
75
Positive
The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.15, reflecting conservative leverage. The equity ratio is high at 79.46%, indicating financial stability. However, ROE has decreased from 9.24% to 2.26%, which highlights a decline in profitability despite strong equity. Overall, the balance sheet suggests a sound financial position with low leverage but reduced returns on equity.
Cash Flow
70
Positive
Free cash flow increased by 20.19%, indicating improved cash generation despite declining revenue. The operating cash flow to net income ratio is robust at 5.58, demonstrating strong cash flow management. However, the free cash flow to net income ratio is at 4.04, which, while positive, reflects decreased net income. The cash flow statement shows resilience in cash generation amidst declining profitability.
BreakdownTTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income Statement
Total Revenue72.49M62.21M79.88M70.66M60.51M88.28M
Gross Profit20.62M16.86M23.74M21.66M18.24M29.71M
EBITDA7.77M3.87M10.88M11.95M10.23M19.04M
Net Income4.53M1.51M6.21M7.13M6.00M12.49M
Balance Sheet
Total Assets81.44M84.39M86.20M90.77M78.73M81.49M
Cash, Cash Equivalents and Short-Term Investments15.38M12.26M9.44M10.11M9.09M9.24M
Total Debt6.03M10.39M11.71M12.08M14.19M14.62M
Total Liabilities13.49M17.32M19.05M27.73M20.32M23.92M
Stockholders Equity67.95M67.07M67.15M63.04M58.42M57.57M
Cash Flow
Free Cash Flow18.51M6.13M5.10M4.51M6.40M6.11M
Operating Cash Flow20.34M8.45M6.74M5.93M8.23M6.66M
Investing Cash Flow-2.42M-2.97M-2.53M-1.43M-1.83M-4.02M
Financing Cash Flow-10.60M-2.66M-4.88M-3.49M-6.55M-1.67M

Clover Corporation Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.54
Price Trends
50DMA
0.47
Positive
100DMA
0.46
Positive
200DMA
0.46
Positive
Market Momentum
MACD
0.02
Negative
RSI
61.65
Neutral
STOCH
62.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CLV, the sentiment is Positive. The current price of 0.54 is above the 20-day moving average (MA) of 0.51, above the 50-day MA of 0.47, and above the 200-day MA of 0.46, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 61.65 is Neutral, neither overbought nor oversold. The STOCH value of 62.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:CLV.

Clover Corporation Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (59)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AUCLV
64
Neutral
AU$91.85M20.306.80%2.73%15.48%135.65%
59
Neutral
AU$1.64B9.6811.24%3.68%6.75%3.18%
AUBUB
51
Neutral
AU$160.76M-21.85%30.54%88.42%
AUBUB
51
Neutral
AU$160.76M-21.85%30.54%88.42%
AUHCT
47
Neutral
AU$19.77M
-5.86%98.26%
AUHCT
47
Neutral
AU$19.77M
-5.86%98.26%
AUNUC
45
Neutral
AU$23.47M-47.74%43.14%51.35%
AUNUC
45
Neutral
AU$23.47M-47.74%43.14%51.35%
AUAHF
41
Neutral
AU$31.59M-23.00%-2.14%11.40%
AUAHF
41
Neutral
AU$31.59M-23.00%-2.14%11.40%
AUNGS
31
Underperform
AU$3.70M
-16.29%58.77%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:CLV
Clover Corporation Limited
0.54
0.06
12.50%
AU:AHF
Australian Dairy Nutritionals Group
0.04
0.02
90.91%
AU:AHF
Australian Dairy Nutritionals Group
0.04
0.02
90.91%
AU:BUB
Bubs Australia Ltd.
0.18
0.05
38.46%
AU:BUB
Bubs Australia Ltd.
0.18
0.05
38.46%
AU:NUC
Nuchev Pty Ltd
0.16
-0.02
-11.11%
AU:NUC
Nuchev Pty Ltd
0.16
-0.02
-11.11%
AU:HCT
Holista Colltech Limited
0.06
0.05
500.00%
AU:HCT
Holista Colltech Limited
0.06
0.05
500.00%
AU:NGS
Nutritional Growth Solutions Ltd.
0.02
>-0.01
-33.33%

Clover Corporation Limited Corporate Events

Clover Corporation Expects Strong FY25 Financial Performance
Jun 11, 2025

Clover Corporation Limited announced an expected outperformance in its unaudited Net Profit After Tax (NPAT) for FY25, surpassing market consensus by approximately 20%. The company’s full-year sales are also anticipated to exceed expectations, driven by a favorable product and customer mix, enhanced performance at Melody Dairies and Ecuador operations, and beneficial currency movements. CEO Peter Davey highlighted the strong contribution from Ecuador as a key factor in the company’s global production footprint, emphasizing the company’s robust balance sheet and continued momentum into FY26.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$0.60 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 13, 2025